BIOCEPT, INC.Employment Agreement • April 17th, 2023 • Biocept Inc • Services-medical laboratories
Contract Type FiledApril 17th, 2023 Company IndustryBiocept, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Chief Legal and Compliance Officer (“CLO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
September 9, 2022 Douglas Samuelson, CPA (inactive)Employment Agreement • January 10th, 2023 • Genelux Corp • Pharmaceutical preparations
Contract Type FiledJanuary 10th, 2023 Company IndustryGenelux Corporation (the “Company”) is pleased to offer you at-will employment in the position of Vice President, Finance on the terms and conditions set forth in this letter agreement (this “Agreement”).
September 29, 2021 Mr. Sean RyderEmployment Agreement • January 10th, 2023 • Genelux Corp • Pharmaceutical preparations
Contract Type FiledJanuary 10th, 2023 Company IndustryGenelux Corporation (the “Company”) is pleased to offer you at-will employment in the position of General Counsel and Corporate Secretary on the terms and conditions set forth in this letter agreement (this “Agreement”).
INTRINSIC MEDICINE, INC.Employment Agreement • April 8th, 2022 • Intrinsic Medicine, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 8th, 2022 Company IndustryIntrinsic Medicine, Inc. (the “Company”) is pleased to offer you continuing at-will employment in the position of Chief Medical Officer on the terms and conditions set forth in this letter agreement (the “Agreement”).
INTRINSIC MEDICINE, INC.Employment Agreement • April 8th, 2022 • Intrinsic Medicine, Inc. • Biological products, (no disgnostic substances) • California
Contract Type FiledApril 8th, 2022 Company Industry JurisdictionIntrinsic Medicine, Inc. (the “Company”) is pleased to offer you continuing at-will employment in the position of President and Chief Operating Officer on the terms and conditions set forth in this letter agreement (the “Agreement”).
INTRINSIC MEDICINE, INC.Employment Agreement • April 8th, 2022 • Intrinsic Medicine, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledApril 8th, 2022 Company IndustryIntrinsic Medicine, Inc. (the “Company”) is pleased to offer you continuing at-will employment in the position of Chief Executive Officer on the terms and conditions set forth in this letter agreement (the “Agreement”).
BIOCEPT, INC.Employment Agreement • March 8th, 2022 • Biocept Inc • Services-medical laboratories
Contract Type FiledMarch 8th, 2022 Company IndustryBiocept, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Chief Operations Officer (“COO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
BIOCEPT, INC.Employment Agreement • February 16th, 2022 • Biocept Inc • Services-medical laboratories
Contract Type FiledFebruary 16th, 2022 Company IndustryBiocept, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Interim Chief Financial Officer (“Interim CFO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
BIOCEPT, INC.Employment Agreement • February 16th, 2022 • Biocept Inc • Services-medical laboratories
Contract Type FiledFebruary 16th, 2022 Company IndustryBiocept, Inc. (the “Company”) is pleased to offer you at-will employment in the position of Interim Chief Executive Officer (“Interim CEO”) on the terms and conditions set forth in this letter agreement (the “Agreement”).
Longboard Pharmaceuticals, Inc.Employment Agreement • March 8th, 2021 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 8th, 2021 Company IndustryYou are currently employed by Longboard Pharmaceuticals, Inc. (the “Company”) under the terms of an offer letter between you and the Company dated January 15, 2021 (the “Offer Letter”). The Company is amending and restating the terms of the Offer Letter to reflect your continued employment terms as set forth in this employment agreement (the “Agreement”). Provided you accept this Agreement by signing and returning it to the Company, this Agreement will become effective as of the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “IPO Date”) and upon such IPO Date, shall supersede and replace your Offer Letter in its entirety, and this Agreement shall then govern the terms of your employment with the Company.
Longboard Pharmaceuticals, Inc.Employment Agreement • March 8th, 2021 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 8th, 2021 Company IndustryYou are currently employed by Longboard Pharmaceuticals, Inc. (the “Company”) under the terms of an offer letter between you and the Company dated October 27, 2020 (the “Offer Letter”). The Company is amending and restating the terms of the Offer Letter to reflect your continued employment terms as set forth in this employment agreement (the “Agreement”). Provided you accept this Agreement by signing and returning it to the Company, this Agreement will become effective as of the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “IPO Date”) and upon such IPO Date, shall supersede and replace your Offer Letter in its entirety, and this Agreement shall then govern the terms of your employment with the Company.
Longboard Pharmaceuticals, Inc.Employment Agreement • March 8th, 2021 • Longboard Pharmaceuticals, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 8th, 2021 Company IndustryYou are currently employed by Longboard Pharmaceuticals, Inc. (the “Company”) under the terms of an offer letter between you and the Company dated November 6, 2020 (the “Offer Letter”). The Company is amending and restating the terms of the Offer Letter to reflect your continued employment terms as set forth in this employment agreement (the “Agreement”). Provided you accept this Agreement by signing and returning it to the Company, this Agreement will become effective as of the date of the underwriting agreement between the Company and the underwriter(s) managing the initial public offering of the Company’s common stock, pursuant to which such common stock is priced for the initial public offering (the “IPO Date”) and upon such IPO Date, shall supersede and replace your Offer Letter in its entirety, and this Agreement shall then govern the terms of your employment with the Company.